JP2022515156A5 - - Google Patents
Info
- Publication number
- JP2022515156A5 JP2022515156A5 JP2021535751A JP2021535751A JP2022515156A5 JP 2022515156 A5 JP2022515156 A5 JP 2022515156A5 JP 2021535751 A JP2021535751 A JP 2021535751A JP 2021535751 A JP2021535751 A JP 2021535751A JP 2022515156 A5 JP2022515156 A5 JP 2022515156A5
- Authority
- JP
- Japan
- Prior art keywords
- deuterium
- pharmaceutically acceptable
- compound
- acceptable salt
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024147359A JP2024163142A (ja) | 2018-12-21 | 2024-08-29 | ボリナンセリンの重水素化形態および誘導体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862784056P | 2018-12-21 | 2018-12-21 | |
| US62/784,056 | 2018-12-21 | ||
| PCT/US2019/067885 WO2020132461A1 (en) | 2018-12-21 | 2019-12-20 | Deuterated forms and derivatives of volinanserin |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024147359A Division JP2024163142A (ja) | 2018-12-21 | 2024-08-29 | ボリナンセリンの重水素化形態および誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022515156A JP2022515156A (ja) | 2022-02-17 |
| JP2022515156A5 true JP2022515156A5 (enExample) | 2022-10-21 |
| JP7548906B2 JP7548906B2 (ja) | 2024-09-10 |
Family
ID=71101633
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021535751A Active JP7548906B2 (ja) | 2018-12-21 | 2019-12-20 | ボリナンセリンの重水素化形態および誘導体 |
| JP2024147359A Pending JP2024163142A (ja) | 2018-12-21 | 2024-08-29 | ボリナンセリンの重水素化形態および誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024147359A Pending JP2024163142A (ja) | 2018-12-21 | 2024-08-29 | ボリナンセリンの重水素化形態および誘導体 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20220106272A1 (enExample) |
| EP (1) | EP3897507A4 (enExample) |
| JP (2) | JP7548906B2 (enExample) |
| KR (1) | KR20210124976A (enExample) |
| CN (1) | CN113747870B (enExample) |
| AU (1) | AU2019403391A1 (enExample) |
| BR (1) | BR112021012082A8 (enExample) |
| CA (1) | CA3124399A1 (enExample) |
| EA (1) | EA202191731A1 (enExample) |
| IL (1) | IL284201A (enExample) |
| MX (1) | MX2021007437A (enExample) |
| SG (1) | SG11202106692UA (enExample) |
| WO (1) | WO2020132461A1 (enExample) |
| ZA (1) | ZA202104656B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115057774A (zh) * | 2022-04-28 | 2022-09-16 | 北京绮一舟新材料技术有限公司 | 一种α-氘代羧酸衍生物类化合物及氘代药物的合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2570961C (en) * | 2004-06-21 | 2015-09-01 | University Of Mississippi | Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities |
| US8198305B2 (en) * | 2007-04-13 | 2012-06-12 | Concert Pharmaceuticals Inc. | 1,2-benzisoxazol-3-yl compounds |
| EP2185687A4 (en) * | 2007-08-06 | 2010-11-17 | Merck Sharp & Dohme | TREATMENT OF PSYCHOSES WITH A 5HT2A ANTAGONIST AND AN AGONIST OR AMPLIFIER OF A METABOTROPIC GLUTAMATE RECEPTOR |
| US8609673B2 (en) * | 2008-01-22 | 2013-12-17 | Concert Pharmaceuticals, Inc. | Vandetanib derivatives |
| WO2012039660A1 (en) * | 2010-09-20 | 2012-03-29 | A. Carlsson Research Ab | Phenylpiperidine compounds for the treatment of neurological and psychiatric disorders |
| SG194625A1 (en) * | 2011-05-23 | 2013-12-30 | Sanofi Sa | Process for the preparation of deuterated compounds containing n-alkyl groups |
| LT3135656T (lt) * | 2011-06-20 | 2019-04-25 | H. Lundbeck A/S | Deuterinti 1-piperazin-3-fenilindanai, skirti šizofrenijos gydymui |
| WO2014145718A2 (en) * | 2013-03-15 | 2014-09-18 | Longevity Biotech, Inc. | Peptides comprising non-natural amino acids and methods of making and using the same |
| WO2018023009A1 (en) * | 2016-07-29 | 2018-02-01 | Concert Pharmaceuticals, Inc. | Deuterated lurasidone |
-
2019
- 2019-12-20 MX MX2021007437A patent/MX2021007437A/es unknown
- 2019-12-20 EP EP19900289.0A patent/EP3897507A4/en active Pending
- 2019-12-20 KR KR1020217022981A patent/KR20210124976A/ko not_active Ceased
- 2019-12-20 EA EA202191731A patent/EA202191731A1/ru unknown
- 2019-12-20 CN CN201980092743.7A patent/CN113747870B/zh active Active
- 2019-12-20 CA CA3124399A patent/CA3124399A1/en active Pending
- 2019-12-20 US US17/416,011 patent/US20220106272A1/en not_active Abandoned
- 2019-12-20 JP JP2021535751A patent/JP7548906B2/ja active Active
- 2019-12-20 SG SG11202106692UA patent/SG11202106692UA/en unknown
- 2019-12-20 WO PCT/US2019/067885 patent/WO2020132461A1/en not_active Ceased
- 2019-12-20 AU AU2019403391A patent/AU2019403391A1/en not_active Abandoned
- 2019-12-20 BR BR112021012082A patent/BR112021012082A8/pt not_active Application Discontinuation
-
2021
- 2021-06-20 IL IL284201A patent/IL284201A/en unknown
- 2021-07-05 ZA ZA2021/04656A patent/ZA202104656B/en unknown
-
2024
- 2024-08-29 JP JP2024147359A patent/JP2024163142A/ja active Pending
- 2024-11-08 US US18/941,426 patent/US20250066302A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240350453A1 (en) | Methods of treating neurological and psychiatric disorders | |
| JP2020526534A5 (enExample) | ||
| JP2022535093A5 (enExample) | ||
| RU2015143466A (ru) | Нейроактивные стероиды и способы их применения | |
| JP2022506111A5 (enExample) | ||
| JP2018070614A5 (enExample) | ||
| JP2017531020A5 (enExample) | ||
| JP2021527031A5 (enExample) | ||
| JP2021501151A5 (enExample) | ||
| JP2021525729A5 (enExample) | ||
| JP2021504326A5 (enExample) | ||
| JP2017511339A5 (enExample) | ||
| JP2014520140A5 (enExample) | ||
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| JP2020504156A5 (enExample) | ||
| JP2022549335A5 (enExample) | ||
| RU2004132856A (ru) | Фармацевтический препарат с модифицированным высвобождением | |
| JPWO2019160057A5 (enExample) | ||
| JP2022519744A5 (enExample) | ||
| JP2019520344A5 (enExample) | ||
| PT98427A (pt) | Metodo para tratamento de doencas do sistema nervoso central com compostos amino-alcoois heterociclicos | |
| JP2016530304A (ja) | チエノピペリジン誘導体およびその使用 | |
| JP2018529666A5 (enExample) | ||
| JP2019529460A5 (enExample) | ||
| JP2024522183A5 (enExample) |